SCHEMBL3148686

SCHEMBL3148686

CC(C)(C)c1ccc(Oc2ccc(O)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.73
TYR P14679 1/20 0.73
ESR1 P03372 2/20 0.64
ESR2 Q92731 2/20 0.64
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
HPGD P15428 2/20 0.63
MAPT P10636 2/20 0.63
NPC1 O15118 1/20 0.63
ALDH1A1 P00352 1/20 0.63
MAPK1 P28482 1/20 0.63
RAB9A P51151 1/20 0.63
LTA4H P09960 6/20 0.58
NR1H2 P55055 1/20 0.54
BAX Q07812 1/20 0.54
CYP3A4 P08684 1/20 0.52
AR P10275 1/20 0.52
TSHR P16473 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A4 P31645 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22001052 0.94 LMNA (0.64) LMNATYRESR1ESR2MEN1
SCHEMBL20793944 0.94 LMNA (0.64) LMNATYRESR1ESR2MEN1
SCHEMBL25947115 0.94 LMNA (0.64) LMNATYRESR1ESR2MEN1
SCHEMBL19008969 0.89 LMNA (0.57) LMNATYRESR1ESR2MEN1
SCHEMBL18118972 0.88 RAB9A (0.77) LMNATYRMEN1KMT2AHPGD
SCHEMBL427816 0.88 RAB9A (0.77) LMNATYRMEN1KMT2AHPGD
SCHEMBL127279 0.88 RAB9A (0.77) LMNATYRMEN1KMT2AHPGD
SCHEMBL24215587 0.87 ELANE (0.60) LMNATYRESR1ESR2MEN1
SCHEMBL14301546 0.87 ELANE (0.60) LMNATYRESR1ESR2MEN1
SCHEMBL20274247 0.87 ELANE (0.60) LMNATYRESR1ESR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137193-B1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI SA (FR) 2017-08-09 EP disclosed
US-8642603-B2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI (FR) 2014-02-04 US disclosed
US-20120053179-A1 Rho-Kinase Inhibitors NAGARATHNAM DHANAPALAN (US) 2012-03-01 US disclosed
US-20120053179-A1 Rho-Kinase Inhibitors NAGARATHNAM DHANAPALAN (US) 2012-03-01 US disclosed
US-7932283-B2 Fungicide N-cyclopropyl-sulfonylamide derivatives BAYER CROPSCIENCE AG (DE) 2011-04-26 US disclosed
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2010-03-25 US disclosed
EP-2137193-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF Sanofi-Aventis (FR) 2009-12-30 EP disclosed
US-20090137611-A1 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives BAYER CROPSCIENCE AG (DE) 2009-05-28 US disclosed
WO-2008112483-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2008-09-18 WO disclosed
US-5155130-A Lipoxygenase inhibitors CIBA-GEIGY CORPORATION (US) 1992-10-13 US disclosed
EP-0412939-A2 Certain benzopyran and benzothiopyran derivatives CIBA-GEIGY AG (CH) 1991-02-13 EP disclosed
EP-0004334-B1 CARBAMATES AND THEIR PESTICIDAL COMPOSITIONS, PREPARATIONS THEREOF AND USE THEREOF AS PESTICIDES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1981-10-21 EP disclosed
US-4215139-A PESTICIDES, INSECTICIDES HOFFMANN-LA ROCHE INC. (US) 1980-07-29 US disclosed
EP-0004334-A1 Carbamates and their pesticidal compositions, preparations thereof and use thereof as pesticides F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1979-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053179-A1 Rho-Kinase Inhibitors CIT, ROCK1, ROCK2 LMNA 3296/4885TYR 561/4885ESR1 2325/4885
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF GRM2, GRM1, GRIN2C LMNA 3882/4885TYR 2608/4885ESR1 699/4885
US-20090137611-A1 Fungicide N-Cyclopropyl-Sulfonylamide Derivatives CYP51A1, ERG28, CBR3 LMNA 3073/4885TYR 1337/4885ESR1 4253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.